Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

Clinical trial NCT05933395 · RECRUITING

Trial details

NCT number: NCT05933395
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2024-09-23
Primary completion: 2030-10-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.